CN Patent
CN111132670A — 具有增强的渗透的药物组合物
Assigned to Aquestive Therapeutics Inc · Expires 2020-05-08 · 6y expired
What this patent protects
描述了具有增强的活性成分渗透性质的药物组合物。
USPTO Abstract
描述了具有增强的活性成分渗透性质的药物组合物。
Drugs covered by this patent
- Mitozytrex (MITOMYCIN) · Kyowa Kirin Co., Ltd.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.